The News Feed

News

Visual System May Serve as Ideal Model for MS Drug Assessment

The neurodegenerative disease can be difficult to track in terms of remyelination, but certain agents can be monitored through ocular imaging to gauge efficacy.
April 26, 2024

Nutraceutical for Dry Eye Coming This Fall

Bausch + Lomb previewed a forthcoming product and pointed to company-funded research showing treatment effects possible after two, four and eight weeks of daily use.
April 26, 2024

Vision-related QoL Unchanged After Trabeculectomy

This research highlights the importance of using both objective and subjective measures to evaluate glaucoma patients and treatment outcomes.
April 26, 2024

Prenatal Carotenoid Supplementation Benefits Both Mother and Child

The regimen improved foveal maturity among infants as well as maternal levels of macular pigment, study shows.
April 26, 2024

Smoking Reduces ONH Vessel Density in Glaucoma

Study shows a dose-dependent association with faster deterioration over time.
April 25, 2024

AREDS Report Updates Simplified Severity Scale

This revision—accounting for reticular pseudodrusen and GA—shows that progression rates are substantially higher when using a more comprehensive approach.
April 25, 2024

Check MRW Measurements over RNFL for Damage from Anti-VEGF Injections

The former is a more sensitive marker for evaluating the effect of frequent injections on the optic nerve head.
April 25, 2024

Glaucoma Med Adherence in First Two Years Predicts Future Patterns

A Danish study of 30,000 patients found increasing age, female sex and low comorbidity score were correlated with better diligence with eye drop treatment for up to 10 years.
April 24, 2024

Meta-analysis Demonstrates Effective, Safe Treatment for Uveitic Macular Edema

The noninfectious form was helped by periocular and intraocular corticosteroids. Newer delivery methods have less evidence supporting their use due to the recency of their introduction.
April 24, 2024

Study Finds Prophylactic LPI Cost-Effective for PACS

To reduce risk of angle closure, researchers strongly suggest considering this intervention in patients without visually significant cataract.
April 23, 2024